Products for Research Use Only
RegisterLogin

NVX-207 (Standard)

CAT: 0804-HY-101597RSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101597RSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NVX-207 (Standard) is the analytical standard of NVX-207. This product is intended for research and analytical applications. NVX-207, a Betulinic acid-derived anti-cancer compound, shows anti-tumor activity (mean IC50=3.5 μM) against various human and canine cell lines. NVX-207-induced apoptosis is associated with activation of the intrinsic apoptotic pathway via cleavage of caspases -9, -3, -7 and of PARP[1].
CAS Number
745020-66-0
Target
Apoptosis; Reference Standards
Related Pathways
Apoptosis; Others
Field of Research
Cancer
Smiles
O=C([C@]1(CC[C@H]2C(C)=C)[C@@]2([H])[C@](CC[C@@]3([H])[C@]4(CC[C@]5([H])[C@@]3(CC[C@H](OC(C)=O)C5(C)C)C)C)([H])[C@@]4(C)CC1)OCC(CO)(N)CO
Molecular Formula
C36H59NO6
Molecular Weight
601.86
References & Citations
[1]Willmann M, et al. Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound. Eur J Clin Invest. 2009;39 (5) :384-394.|[2]Bache M, et al. Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. Int J Mol Sci. 2014 Oct 30;15 (11) :19777-90.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards

Related Products

CatalogName
HY-101597-01NVX-207
HY-108930HI-207
HY-114841-01ONO 207
HY-1112514SC-207
HY-120028-01GNE-207
HY-111916-01ODM-207
HY-W947258CRBN ligand-207
HY-162451Antibacterial agent 207
HY-163515Anticancer agent 207
HY-178962Antitumor agent-207

Alternative Products

CatalogName
BA3162-10NVX-207
A13630-100NVX-207 100mg
A13630-50NVX-207 50mg
A13630-10NVX-207 10mg
A13630-5NVX-207 5mg
A13630-25NVX-207 25mg
T33765-01NVX-108
BA4687-1GNE-207
HWD17757-01BAY-207
GTR19197532-01HI-207

Popular Products